摘要
目的研究卵巢癌术后化疗联合醋酸甲羟孕酮抑制盆腔病理血管生成分析。方法收取我院60例卵巢癌患者,分为两组,观察组采用化疗联合醋酸甲羟孕酮,对照组采用化疗。结果观察组Ⅲ/Ⅱ期患者病理血管分支10支与对照组Ⅲ/Ⅱ期患者病理血管分支16支相比,差异有统计学意义,P<0.05,手术后1年,观察组患者病理血管分支少于对照组,P<0.05,观察组患者生存率、1年生存率90.00%高于对照组,P<0.05。结论卵巢癌术后化疗联合醋酸甲羟孕酮能有效抑制盆腔病理血管的生成。
Objective To study the effects of chemotherapy combined with Progesterone Acetate in the treatment of ovarian cancer after surgical treatment of pelvic pathological blood vessel formation. Methods 60 cases of ovarian cancer in our hospital were divided into two groups,the observation group was treated with chemotherapy combined with acetic acid,the control group was treated with chemotherapy. Results Observation group III / II patients with pathological blood vessel branch 10 and control group III / II patients with pathological blood vessel branch 16 compared,the difference was statistically significant,P〈0.05,1 years after the surgery,the observation group of patients with pathological vascular branches less than the control group,P〈0.05,the survival rate of patients in the observation group,1 year survival rate was 90% higher than the control group,P〈0.05. Conclusion Chemotherapy combined with Progesterone Acetate after ovarian cancer surgery can effectively inhibit the formation of pathological blood vessels in the pelvis.
出处
《中国卫生标准管理》
2016年第21期151-152,共2页
China Health Standard Management
关键词
化疗
卵巢癌
醋酸甲羟孕酮
Chemotherapy
Ophoroma
Progesterone acetate